These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38191677)

  • 1. Levels of neuronal pentraxin 2 in plasma is associated with cognitive function in patients with schizophrenia.
    Zhou J; Li X; Wang X; Yang Y; Nai A; Shi H; Zhao J; Zhang J; Ding S; Han Y; Liu Q; Zhang L; Chen T; Liu B; Yue W; Lv L; Li W
    Psychopharmacology (Berl); 2024 Apr; 241(4):865-874. PubMed ID: 38191677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P50 sensory gating, cognitive deficits and depressive symptoms in first-episode antipsychotics-naïve schizophrenia.
    Li S; Yu B; Wang D; Xia L; Wang L; Chen D; Xiu M; Zhang XY
    J Affect Disord; 2023 Mar; 324():153-161. PubMed ID: 36587903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuronal pentraxin-2 (NPTX2) serum levels during an acute psychotic episode in patients with schizophrenia.
    Göverti D; Büyüklüoğlu N; Kaya H; Yüksel RN; Yücel Ç; Göka E
    Psychopharmacology (Berl); 2022 Aug; 239(8):2585-2591. PubMed ID: 35482070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the mRNA expression level of RELN in peripheral blood of schizophrenia patients before and after antipsychotic treatment.
    Yin J; Lu Y; Yu S; Dai Z; Zhang F; Yuan J
    Hereditas; 2020 Nov; 157(1):43. PubMed ID: 33158463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pattern of gene expression in different stages of schizophrenia: Down-regulation of NPTX2 gene revealed by a meta-analysis of microarray datasets.
    Manchia M; Piras IS; Huentelman MJ; Pinna F; Zai CC; Kennedy JL; Carpiniello B
    Eur Neuropsychopharmacol; 2017 Oct; 27(10):1054-1063. PubMed ID: 28732597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superoxide Dismutase, BDNF, and Cognitive Improvement in Drug-Naive First-Episode Patients With Schizophrenia: A 12-Week Longitudinal Study.
    Wu Z; Liu Q; Zhang Y; Guan X; Xiu M; Zhang X
    Int J Neuropsychopharmacol; 2022 Feb; 25(2):128-135. PubMed ID: 34622272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive deficits and white matter abnormalities in never-treated first-episode schizophrenia.
    Yang M; Gao S; Zhang X
    Transl Psychiatry; 2020 Nov; 10(1):368. PubMed ID: 33139736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P50 inhibition deficit in patients with chronic schizophrenia: Relationship with cognitive impairment of MATRICS consensus cognitive battery.
    Xia L; Yuan L; Du XD; Wang D; Wang J; Xu H; Huo L; Tian Y; Dai Q; Wei S; Wang W; Trihn TH; Alnatour OI; Chen D; Xiu M; Wang L; Yang M; Zhang XY
    Schizophr Res; 2020 Jan; 215():105-112. PubMed ID: 31780341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of P50 with social function, but not with cognition in patients with first-episode schizophrenia.
    Wang D; Xia L; Zhang Z; Guo J; Tian Y; Zhou H; Xiu M; Chen D; Zhang XY
    Eur Arch Psychiatry Clin Neurosci; 2023 Nov; ():. PubMed ID: 37966511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smoking affects the association between cognitive impairment and P50 inhibition defects in patients with chronic schizophrenia: A case-control study.
    Wang DM; Xia LY; Zhou HX; Tian Y; Dai QL; Xiu MH; Chen DC; Wang L; Zhang XY
    Asian J Psychiatr; 2023 Jan; 79():103391. PubMed ID: 36516649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive clustering in schizophrenia patients, their first-degree relatives and healthy subjects is associated with anterior cingulate cortex volume.
    Ohi K; Shimada T; Nemoto K; Kataoka Y; Yasuyama T; Kimura K; Okubo H; Uehara T; Kawasaki Y
    Neuroimage Clin; 2017; 16():248-256. PubMed ID: 28831376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune dysregulation is associated with symptom dimensions and cognitive deficits in schizophrenia: accessible evidence from complete blood count.
    Zhou L; Ma X; Wang W
    BMC Psychiatry; 2024 Jan; 24(1):48. PubMed ID: 38216897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathologically Decreased CSF Levels of Synaptic Marker NPTX2 in DLB Are Correlated with Levels of Alpha-Synuclein and VGF.
    Boiten WA; van Steenoven I; Xiao MF; Worley PF; Noli B; Cocco C; Ferri GL; Lemstra AW; Teunissen CE
    Cells; 2020 Dec; 10(1):. PubMed ID: 33383752
    [No Abstract]   [Full Text] [Related]  

  • 14. Common and Distinct Alterations of Cognitive Function and Brain Structure in Schizophrenia and Major Depressive Disorder: A Pilot Study.
    Ma M; Zhang Y; Zhang X; Yan H; Zhang D; Yue W
    Front Psychiatry; 2021; 12():705998. PubMed ID: 34354618
    [No Abstract]   [Full Text] [Related]  

  • 15. A proof-of-concept, randomized controlled trial of DAR-0100A, a dopamine-1 receptor agonist, for cognitive enhancement in schizophrenia.
    Girgis RR; Van Snellenberg JX; Glass A; Kegeles LS; Thompson JL; Wall M; Cho RY; Carter CS; Slifstein M; Abi-Dargham A; Lieberman JA
    J Psychopharmacol; 2016 May; 30(5):428-35. PubMed ID: 26966119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered Signaling in CB1R-5-HT2AR Heteromers in Olfactory Neuroepithelium Cells of Schizophrenia Patients is Modulated by Cannabis Use.
    Guinart D; Moreno E; Galindo L; Cuenca-Royo A; Barrera-Conde M; Pérez EJ; Fernández-Avilés C; Correll CU; Canela EI; Casadó V; Cordomi A; Pardo L; de la Torre R; Pérez V; Robledo P
    Schizophr Bull; 2020 Dec; 46(6):1547-1557. PubMed ID: 32249318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuronal pentraxin 2: a synapse-derived CSF biomarker in genetic frontotemporal dementia.
    van der Ende EL; Xiao M; Xu D; Poos JM; Panman JL; Jiskoot LC; Meeter LH; Dopper EG; Papma JM; Heller C; Convery R; Moore K; Bocchetta M; Neason M; Peakman G; Cash DM; Teunissen CE; Graff C; Synofzik M; Moreno F; Finger E; Sánchez-Valle R; Vandenberghe R; Laforce R; Masellis M; Tartaglia MC; Rowe JB; Butler CR; Ducharme S; Gerhard A; Danek A; Levin J; Pijnenburg YA; Otto M; Borroni B; Tagliavini F; de Mendonca A; Santana I; Galimberti D; Seelaar H; Rohrer JD; Worley PF; van Swieten JC;
    J Neurol Neurosurg Psychiatry; 2020 Jun; 91(6):612-621. PubMed ID: 32273328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane lipidomics in schizophrenia patients: a correlational study with clinical and cognitive manifestations.
    Tessier C; Sweers K; Frajerman A; Bergaoui H; Ferreri F; Delva C; Lapidus N; Lamaziere A; Roiser JP; De Hert M; Nuss P
    Transl Psychiatry; 2016 Oct; 6(10):e906. PubMed ID: 27701405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between cortical volume and gray-white matter contrast with second generation antipsychotic medication exposure in first episode male schizophrenia patients.
    Chwa WJ; Tishler TA; Raymond C; Tran C; Anwar F; Villablanca JP; Ventura J; Subotnik KL; Nuechterlein KH; Ellingson BM
    Schizophr Res; 2020 Aug; 222():397-410. PubMed ID: 32487466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is the optimal neuropsychological test battery for schizophrenia in China?
    Shi C; Kang L; Yao S; Ma Y; Li T; Liang Y; Cheng Z; Xu Y; Shi J; Xu X; Zhang C; Franklin DR; Heaton RK; Jin H; Yu X
    Schizophr Res; 2019 Jun; 208():317-323. PubMed ID: 30718121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.